{'fraction_non_alphanumeric': 0.01989389920424403, 'fraction_numerical': 0.011936339522546418, 'mean_word_length': 5.188524590163935, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Use of small doses of obsidan in physical rehabilitation of patients with myocardial infarct].

A study of 152 patients with transmural or large-focal myocardial infarction was conducted; 82 of them received low doses of Obsidan (40 mg/day) for 14 days during the activization period. The employment of such doses of the drug was found rational for ensuring a more effective activization of the patients who had a persistent pain syndrome, sinus tachycardia, extrasystolic arrhythmias and "ischaemic" changes of ECG in response to definite stages of the kinetic regimen. A decrease of cardiac output noted during the therapy was especially distinct in cases of cardiac aneurysms and corresponded to the alternating conditions of the metabolic processes.